Grant Verstandig - 24 Mar 2022 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/ Ilse Johnson, Attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
24 Mar 2022
Net transactions value
+$750,274
Form type
4
Filing time
28 Mar 2022, 16:15:30 UTC
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Purchase $133,983 +39,995 +5.6% $3.35* 754,890 24 Mar 2022 Direct F1
transaction NEXI Common Stock Purchase $544,915 +131,622 +17% $4.14* 886,512 25 Mar 2022 Direct F2
transaction NEXI Common Stock Purchase $71,376 +18,983 +2.1% $3.76* 905,495 28 Mar 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.02 to $3.50, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.56 to $4.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.57 to $3.98, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.